Cell therapy is not a universal cure for all health conditions. While it aims to provide the body with the necessary tools and optimal conditions to regenerate damaged tissues, individual responses vary. Some patients show significant improvement, while others experience minimal or no noticeable changes.
1. Individual Variability in Response – The effectiveness of cell therapy depends on each person’s unique biological response. While many patients experience substantial recovery, others may not show the same level of progress due to differences in their body’s ability to heal and regenerate.
2. Patient-Specific Healing Ability – The outcome of any treatment is influenced by the individual’s capacity for tissue repair. Since every body functions differently, it is impossible to standardize results or apply a one-size-fits-all approach. Below is a list of conditions where our clinical experience has shown the most promising improvements.
3. Lack of a Universal Protocol – There is no single method applicable to all patients. However, based on our ongoing research and clinical data, we have identified specific conditions that respond best to cell therapy. This list continues to evolve as new advancements emerge.
Key Limitations of Cell Therapy
1. Limited Stem Cell Production – If a patient’s bone marrow has a reduced capacity to produce stem cells, the number of harvested cells will be insufficient for effective transplantation. Although stem cells have the ability to detect damaged tissue, physical barriers (such as blocked arteries) may prevent them from reaching the affected areas. If these obstructions are not removed, tissue regeneration will be slow, minimal, or nonexistent.
2. Potential Risks in Cancer Treatment – Due to limited medical knowledge regarding cancer and stem cells, introducing progenitor cells could inadvertently accelerate tumor growth. As a result, cell therapy for cancer requires further research and a deeper understanding before it can be widely implemented. At present, our treatments are restricted to non-cancerous conditions. Additionally, the quality of stem cells plays a crucial role in effectiveness. Older individuals, particularly those above 74, produce fewer stem cells, which can limit the success of the therapy.